Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Artificial antigen-presenting cell prepared from HLA-null cell line by using multiplex CRISPR-CAS9 system and use thereof

Artificial antigen-presenting cell prepared from HLA-null cell line by using multiplex CRISPR-CAS9 system and use thereof

US Patent 11859207 · Granted Jan 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Exosome for stimulating T cell and pharmaceutical use thereof2025
Exosome for stimulating T cell and pharmaceutical use thereof2025
Feeder cell and method for growing gamma delta T cells by using same2024
Feeder cell and method for growing gamma delta T cells by using same2024
HLA-A2 subtype-specific PLK1-derived epitope inducing antigen-specific t cell im2024
Exosome for stimulating T cell and pharmaceutical use thereof2023
Exosome for stimulating T cell and pharmaceutical use thereof2023
EBV antigen specific T-cell receptor and use thereof2019
EBV antigen specific T-cell receptor and use thereof2018
CD4 T cell vaccine and use thereof2017
Tumor antigen proteins or genes of polo-like kinase 12015
Display apparatus for determining error in display identification data and contr2013